tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TNGX Stock Latest News

Tango Therapeutics: Promising Efficacy and Strategic Expansion Justify Buy Rating
RatingsTango Therapeutics: Promising Efficacy and Strategic Expansion Justify Buy Rating
1M ago
TNGX
Tango Therapeutics Advances Cancer Treatment Pipeline
PremiumCompany Announcements
Tango Therapeutics Advances Cancer Treatment Pipeline
1M ago
TNGX
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
PremiumThe Fly
Tango Therapeutics reports Q4 EPS (35c), consensus (34c)
1M ago
TNGX
Tango Therapeutics sees cash runway into 3Q26
PremiumThe Fly
Tango Therapeutics sees cash runway into 3Q26
1M ago
TNGX
Tango Therapeutics Highlights Breakthroughs in Cancer Treatment
PremiumCompany Announcements
Tango Therapeutics Highlights Breakthroughs in Cancer Treatment
3M ago
8K
TNGX
Tango Therapeutics treatment of pancreatic cancer granted orphan designation
PremiumThe FlyTango Therapeutics treatment of pancreatic cancer granted orphan designation
4M ago
TNGX
Tango Therapeutics price target lowered to $8 from $16 at B. Riley
Premium
The Fly
Tango Therapeutics price target lowered to $8 from $16 at B. Riley
5M ago
TNGX
Tango Therapeutics price target lowered to $8 from $18 at Guggenheim
Premium
The Fly
Tango Therapeutics price target lowered to $8 from $18 at Guggenheim
5M ago
TNGX
Tango Therapeutics Advances Cancer Treatment Pipeline
PremiumCompany Announcements
Tango Therapeutics Advances Cancer Treatment Pipeline
5M ago
TNGX
Trump Media, broader market surge after Trump wins election: Morning Buzz
PremiumThe Fly
Trump Media, broader market surge after Trump wins election: Morning Buzz
5M ago
OC
CVS
Tango Therapeutics reports Q3 EPS (27c), consensus (37c)
PremiumThe Fly
Tango Therapeutics reports Q3 EPS (27c), consensus (37c)
5M ago
TNGX
Tango Therapeutics announces update on PRMT5 program
PremiumThe Fly
Tango Therapeutics announces update on PRMT5 program
5M ago
TNGX
Short Report: Archer Aviation shorts at seven-week high
PremiumThe FlyShort Report: Archer Aviation shorts at seven-week high
5M ago
ACHR
BMEA
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
8M ago
INZY
TNGX
Tango Therapeutics price target raised to $13 from $11 at Wedbush
Premium
The Fly
Tango Therapeutics price target raised to $13 from $11 at Wedbush
8M ago
TNGX
Tango Therapeutics reports Q2 EPS (24c), consensus (34c)
PremiumThe Fly
Tango Therapeutics reports Q2 EPS (24c), consensus (34c)
8M ago
GILD
TNGX
Tango Therapeutics initiated with a Buy at Jefferies
PremiumThe Fly
Tango Therapeutics initiated with a Buy at Jefferies
9M ago
TNGX
Tango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
PremiumThe Fly
Tango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
10M ago
TNGX
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
PremiumThe Fly
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
11M ago
TNGX
Tango Therapeutics price target lowered to $13 from $18 at Barclays
PremiumThe FlyTango Therapeutics price target lowered to $13 from $18 at Barclays
11M ago
TNGX
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
Premium
The Fly
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
11M ago
TNGX
Tango Therapeutics to discontinue development of TNG348 program
Premium
The Fly
Tango Therapeutics to discontinue development of TNG348 program
11M ago
TNGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >